Shkreli says he isn’t responsible for Daraprim ‘monopoly’

Jailed ‘pharma bro’ Martin Shkreli has told a US federal court he is not responsible for antitrust violations alleged by the US Federal Trade Commission (FTC).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

States join antitrust suit against ‘pharma bro’ Shkreli

16 April 2020 Six state attorneys have joined a suit filed against incarcerated ‘pharma bro’ Martin Shkreli and his company Vyera Pharmaceuticals for allegedly monopolising the market for a life-saving drug.

Big Pharma

Shkreli inflated price of life-saving drug from federal prison, FTC says

14 August 2020 Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission.

Big Pharma

Judge issues mixed ruling on Shkreli attorney communications

21 August 2020 The FTC should avoid reviewing communications between Martin Shkreli and his attorneys, but these are not protected under the Privacy Act, a New York federal judge has ruled.

More on this story

Americas

States join antitrust suit against ‘pharma bro’ Shkreli

Big Pharma

Shkreli inflated price of life-saving drug from federal prison, FTC says

14 August 2020 Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission.

Big Pharma

Judge issues mixed ruling on Shkreli attorney communications

21 August 2020 The FTC should avoid reviewing communications between Martin Shkreli and his attorneys, but these are not protected under the Privacy Act, a New York federal judge has ruled.

More on this story

Americas

States join antitrust suit against ‘pharma bro’ Shkreli

Big Pharma

Shkreli inflated price of life-saving drug from federal prison, FTC says

14 August 2020 Martin Shkreli conspired to illegally increase the price of a life-saving drug during phone calls he made from prison, according to the US Federal Trade Commission.

Big Pharma

Judge issues mixed ruling on Shkreli attorney communications

21 August 2020 The FTC should avoid reviewing communications between Martin Shkreli and his attorneys, but these are not protected under the Privacy Act, a New York federal judge has ruled.

More features

Gilead scores win in fake HIV drug dispute

Polsinelli grows roster with ex-corporate counsel

‘Don’t rely on national case law’ at the UPC: Wouter Pors, Bird & Bird

Sandoz wins $137.2m payout for lost profits in generic launch

Sanofi signs global rights deal to develop rare cancer therapy

Unified Patent Court visualised: Cases, divisions, and classes in charts

WBD to merge with firm to create ‘powerhouse’ practice

‘Be prepared, and don’t assume at the UPC’: Christopher Stothers

Shkreli says he isn’t responsible for Daraprim ‘monopoly’

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features